Programme for 2024/2025
Series of stand-alone webinars developed and delivered by LILLY, with local involvement from NHS specialists will run from September 2024 through to July 2025.
These webinars are non-promotional and will cover a variety of topics. The intended audience is GPs, Practice Nurses and Practice based Pharmacists in Primary Care, however they are open to anyone caring for patients with diabetes.
Modular Rolling Programme
All sessions will be 12.30-1.30 and you may register for as many as you like.
Tuesday 7th January 2025
‘Oral therapies for patients with T2 diabetes (part 1)’
Wednesday 12th February 2025
‘Oral therapies for patients with T2 diabetes (part 2)’
Wednesday 19th March 2025
‘Promoting Effective Change’
Tuesday 6th May 2025
‘Younger Adults with T2 diabetes- treating patients aged <40 years’
Wednesday 18th June 2025
TBC
To register contact: loth.diabetesmcneducation@nhs.scot
Learning Outcomes
Tuesday 7th January 2025 ‘Oral therapies for patients with T2 diabetes (part 1)’
- Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes
- Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs
- Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease
- Recognise the need to consider therapy specific factors and the individual patient’s circumstances when choosing between different oral therapies
Wednesday 12th February 2025 ‘Oral therapies for patients with T2 diabetes (part 2)’
- Discuss the considerations when choosing a treatment to meet the needs and circumstances of individual adult patients with type 2 diabetes
- Review the standard oral therapies used in the treatment of type 2 diabetes: metformin, sulphonylureas, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and oral GLP-1 RAs
- Understand the sites of action for the different oral drug classes and be aware of the prescribing considerations including renal function and hepatic disease
- Recognise the need to consider therapy specific factors and the individual patient’s circumstances when choosing between different oral therapies
Wednesday 19th March 2025 ‘ Promoting Effective Change’
- To understand how adopting a patient- centred approach can support people with effective change
- To explore potential conversational structure and tools that promote change
- To understand the stages of change model and the nature of ambivalence
- Holistic Approach to Care in Younger Adults with T2D
Tuesday 6th May 2025 ‘Younger Adults with T2 Diabetes- treating patients <40 years’
- The growing problem of T2 diabetes in younger adults
- The importance of early identification and management
- Psychosocial Considerations in younger adults with T2D
Wednesday 18th June 2025 TBC
